AGP Picks
View all

Medmio says its medical coding AI hit 98.1% accuracy on unseen charts

Jul. 22, 2026
By AI, Created 13:00 UTC, Jul 22, 2026, AGP -

Medmio released a public benchmark for its CodeSight AI medical coding engine and says the system matched a vascular practice’s billed level 98.1% of the time on charts it had never seen. The company also published the underlying evidence so the results can be independently checked.

Why it matters: - Medical practices are under pressure to automate billing because experienced coders are in short supply. - Medmio is positioning CodeSight as a reviewable alternative that can assign codes with confidence scores and send uncertain charts to a human coder. - The company is also making a broader claim about transparency in healthcare AI by publishing the full evidence behind the benchmark.

What happened: - Medmio released the Medmio EM-945 benchmark as a public measure of how accurately CodeSight reads clinical notes and assigns billing codes. - On charts the system had never seen, CodeSight matched the exact billing level a vascular practice actually billed 98.1% of the time. - The result carried a 95% confidence interval of 96.2% to 99.1%. - The benchmark was measured without custom training on the practice’s data. - Any chart below Medmio’s confidence threshold was routed to a human coder for review.

The details: - The benchmark was built from 945 billed-and-paid charts. - The test set was locked before the result was measured. - Medmio scored the system against the codes the practice actually billed. - The company published confidence intervals, a calibration analysis and the complete accuracy-coverage curve. - CodeSight is the coding engine inside Medmio’s broader platform, which also includes voice dictation, patient intake and mobile charge capture. - Medmio says CodeSight combines an ensemble of large language models with deterministic, policy-driven rules to keep outputs accurate and consistent. - Medmio says CodeSight integrates with major EHRs via HL7 standards. - The full report is available as a CodeSight Benchmark. - Medmio’s platform also includes autonomous medical coding, voice dictation, patient intake and mobile charge capture.

Between the lines: - The benchmark is limited to office visits at one practice, so the result is a narrow test rather than a broad industry-level validation. - Medmio is using the release to signal that it wants outside verification, not just vendor-controlled claims. - The human-review fallback suggests the company is trying to balance automation with billing risk management.

What's next: - Medmio says it will publish future results the same way. - The company plans to test larger datasets and a broader, more complex range of codes. - Medmio says it wants openness to be a standard for its own technology and, by extension, for healthcare AI more broadly. - CEO Levan Sulakvelidze said the company sees room for higher quality performance as CodeSight is applied to more practices.

The bottom line: - Medmio is not just claiming high coding accuracy; it is also publishing the evidence package behind the claim in a way that invites scrutiny.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.